25.1 (C5H10N, g-C). MS (MALDI): calc. 1807.2050 (M+);
as a white powder. Yield: 3.49 g (499%). 1H NMR (300
MHz, CDCl3) d 6.70–5.49 (br, 18H, NH), 3.79 (br, 24H, CH2,
piperazine), 3.68 (br, 36H, C5H10N, a-H), 3.53 (br, 36H, CH2,
NCH2), 3.34 (br, 12H, CH2, CH2NH–C3N3), 3.02 (br, 24H,
CH2NHBoc), 1.80 (br, 12H, G1-NCH2CH2), 1.66 (br, 24H,
G2-NCH2CH2), 1.58–1.52 (br, 54H, C5H10N, g-C5H10N, b-
H), 1.39 (s, 108H, C(CH3)3). 13C{1H} NMR (75.5 MHz,
CDCl3) d 165.9 (s, C3N3), 165.6 (s, C3N3), 165.2 (s, C3N3),
165.0 (s, C3N3), 156.0 (s, C(O)), 79.0 (s, C(CH3)3), 44.3 (br),
43.3 (br), 42.2 (br), 37.3 (s, CH2NHBoc), 28.7 (s, C(CH3)3),
27.9 (br, NCH2CH2), 26.0 (br, C5H10N, b-C), 25.1 (br,
C5H10N, g-C). MS (MALDI): calc. 4157.3818 (M+); found
4158.6648 (M + H+).
found 1808.3271 (M + H+).
G1-NH2. A 5 M HCl solution (35 mL) was added to a clear
solution of G1-Pip (2.75 g, 1.52 mmol) in CH2Cl2 (3 mL) and
MeOH (70 mL), and the solution was stirred at 25 1C for 15 h.
The volatile components were concentrated in vacuo until only
ca. 15 mL of water remained. The residue was made basic (pH
= 14) with 40 mL of 5 M NaOH (aq.) solution. The resulting
milky suspension was extracted with CHCl3 (5 ꢂ 250 mL). The
combined organic phases were dried with Na2SO4. Following
filtration, the solvent was removed in vacuo to afford the
product as a white solid. Yield: 1.845 g, 499%. 1H NMR
(300 MHz, CDCl3) d 3.79 (br, 24H, CH2, piperazine), 3.71 (br,
3
12H, C5H10N, a-H), 3.63 (br t, JHꢁH = 7 Hz, 12H, pr-
G2-NH2. A concentrated aqueous HCl solution (15 mL)
was added to a solution of G2-Pip (1.35 g, 0.32 mmol) in
MeOH (40 mL), and the clear solution was stirred at 25 1C for
16 h. The volatile components were concentrated in vacuo until
only ca. 5 mL of water remained. The residue was made basic
(pH = 14) with 25 mL of 1 M NaOH (aq.) solution, and the
resulting milky suspension was extracted with CHCl3 (5 ꢂ 250
mL). The organic extractions were combined, and then the
solvent was removed in vacuo to afford the product as a white
solid. Yield: 959 mg, 499%. 1H NMR (300 MHz, CDCl3 with
trace CD3OD) d 5.24 (br, 6H, NH), 3.80 (br, 24H, CH2,
piperazine), 3.73 (br, 12H, G1-C5H10N, a-H), 3.65 (br, 36H,
G2-C5H10N, a-H, NCH2), 3.57 (br, 24H, CH2, NH2NCH2),
3.32 (br, 12H, CH2NH–C3N3), 2.64 (br, 24H, CH2NH2), 1.81
(br, 12H, G1-NCH2CH2), 1.70 (br, 24H, G2-NCH2CH2),
1.58–1.51 (br, 54H, C5H10N, g-H, C5H10N, b-H, and NH2).
13C{1H} NMR (75.5 MHz, CDCl3 with trace CD3OD) d 165.8
(s, C3N3), 165.4 (s, C3N3), 165.2 (s, C3N3), 165.1 (s, C3N3),
165.0 (s, C3N3), 164.6 (s, C3N3), 164.3 (s, C3N3), 43.8 (s,
NCH2), 42.8 (s, NCH2), 41.7 (s, NCH2), 38.1 (s, G2-
CH2NH2), 37.3 (br, G1-CH2NH–C3N3), 30.3 (s, G2-
NCH2CH2), 27.7 (br, G1-NCH2CH2), 25.5 (C5H10N, b-C),
24.6 (C5H10N, g-C). MS (MALDI): calc. 2954.1932 (M+);
found 2955.0237 (M + H+).
NCH2), 2.68 (br t, 3JHꢁH = 7 Hz, 12H, CH2NH2), 1.73 (br m,
12H, NCH2CH2), 1.62 (br, 6H, C5H10N, g-H), 1.54 (br, 24H,
C5H10N, b-H and NH2). 13C{1H} NMR (75.5 MHz, CDCl3) d
165.5 (s, C3N3), 165.2 (s, C3N3), 164.8 (s, C3N3), 44.0 (C5H10N,
a-C), 43.0 (s, CH2, piperazine), 42.4 (s, NH2–NCH2), 39.1 (s,
CH2NH2), 39.0 (s, CH2NH2), 31.3 (s, NCH2CH2), 25.7
(C5H10N, b-C), 24.9 (C5H10N, g-C). MS (MALDI): calc.
1206.8904 (M+); found 1207.9496 (M + H+).
G2-Cl. A solution of G1-NH2 (889 mg, 0.74 mmol), DIPEA
(2.1 mL, 12.5 mmol) and 1 (2.99 g, 6.21 mmol) was prepared in
a THF–water mixture (200 : 10 mL) to give a slurry. The
solution was stirred at 25 1C for 16 h, and then filtered through
Celite. The solvent was removed in vacuo. Purification was
achieved using column chromatography on silica gel (40 : 1
CH2Cl2–MeOH; Rf = 0.19 using 20 : 1 CH2Cl2–MeOH as the
developing solvent) to afford the product as a white solid.
Yield: 2.66 g (93%). The excess/unreacted 1 may also be
recovered from this purification (Rf = 0.50 using 20 : 1
CH2Cl2:MeOH as the developing solvent). 1H NMR (300
MHz, CDCl3) d 6.08 (br, 2H, NH) 5.61 (br, 8H, NH), 5.44
(br, 2H, NH), 4.98 (br, 6H, NH), 3.82 (br, 24H, CH2,
piperazine), 3.74 (br, 12H, C5H10N, a-H), 3.64–3.56 (br,
36H, CH2, NCH2), 3.39 (br, 12H, CH2, CH2NH–C3N3),
3.08 (br, 24H, CH2NHBoc), 1.85 (br, 12H, G1-NCH2CH2),
1.73 (br, 30H, G2-NCH2CH2, C5H10N, g-H), 1.58 (br, 12H,
C5H10N, b-H), 1.43 (s, 54H, C(CH3)3), 1.41 (s, 54H, C(CH3)3).
13C{1H} NMR (75.5 MHz, CDCl3) d 169.2 (s, C3N3), 168.4 (s,
C3N3), 165.4 (s, C3N3), 165.1 (s, C3N3), 164.9 (s, C3N3), 164.6
(s, C3N3), 156.0 (s, C(O)), 155.7 (s, C(O)), 78.9 (s, C(CH3)3),
78.6 (s, C(CH3)3), 44.0 (br), 43.1 (br), 37.6 (s, CH2NHBoc),
36.6 (s, CH2NHBoc), 28.2 (s, C(CH3)3), 27.7 (s, NCH2CH2),
25.6 (C5H10N, b-C), 24.8 (C5H10N, g-C). MS (MALDI): calc.
3865.2622 (M+); found 3868.2945.
G3-Cl. A solution of G3-NH2 (0.234 g, 0.0794 mmol),
DIPEA (0.43 mL, 2.86 mmol) and 1 (0.914 g, 1.9 mmol) was
prepared in a CH2Cl2 (50 mL)–EtOAc (15 mL)–water (5 mL)
mixture to give a slurry. The solution was stirred at 25 1C for
16 h, the solvents removed in vacuo and the residue taken up in
50 mL CH2Cl2. The solution was washed with water (3 ꢂ 100
mL) and brine (1 ꢂ 100 mL). The organic phases were filtered
through silica to remove excess starting material. The solvent
was removed in vacuo and any residual starting materials were
removed by reprecipitation from CH2Cl2 with hexanes to
afford the product as a white solid. Yield: 0.5118 g (78%).
1H NMR (300 MHz, CDCl3) d 9.33, 5.62, 4.98 (br, 42H, NH),
3.75 (br, 24H, CH2, piperazine), 3.65–3.52 (br, 120H, NCH2
and C5H10N, a-H), 3.36–3.29 (br, 36H, CH2NH–C3N3), 3.03
(br, 48H, CH2NHBoc), 1.89 (br, 12H, G1-NCH2CH2), 1.79
(br, 24H, G2-NCH2CH2), 1.68 (br, 48H, G3-NCH2CH2), 1.49
(br, 54H, C5H10N, b-H and g-H), 1.39 (s, 108H, C(CH3)3),
1.37 (s, 108H, C(CH3)3). 13C{1H} NMR (75.5 MHz, CDCl3)
d 169.7 (s, C3N3), 168.8 (s, C3N3), 168.2 (s, C3N3), 165.9
(s, C3N3), 165.6 (s, C3N3), 165.3 (s, C3N3), 165.1 (s, C3N3),
G2-Pip. A clear solution of G2-Cl (3.18 g, 0.823 mmol) and
piperidine (1.5 mL, 14.8 mmol) was prepared in THF (50 mL).
The mixture was stirred at 25 1C for 12 h, and the resulting
slurry was filtered through silica to give a clear solution. The
solvent was removed in vacuo. The solid was washed with
hexanes and dissolved in 50 mL CH2Cl2. The solution was
washed with water (2 ꢂ 50 mL) and brine (1 ꢂ 50 mL). The
organic phases were dried with Na2SO4 and the solvent was
removed in vacuo. The residue was reprecipitated from CH2Cl2
with hexanes, then EtOAc with hexanes to afford the product
ꢀc
This journal is the Royal Society of Chemistry and the Centre National de la Recherche Scientifique 2007
1288 | New J. Chem., 2007, 31, 1283–1290